Viking Therapeutics, Inc. (VKTX) Operating cash flow 2016–2025
Viking Therapeutics, Inc. (VKTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$278.7MFY2025 · since FY2016: -$11.1M → -$278.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$278.7M | -217.4% |
| FY2024 | -$87.8M | -19.6% |
| FY2023 | -$73.4M | -51.6% |
| FY2022 | -$48.4M | -1.7% |
| FY2021 | -$47.6M | -118.5% |
| FY2020 | -$21.8M | +12.0% |
| FY2019 | -$24.8M | -32.0% |
| FY2018 | -$18.8M | -27.1% |
| FY2017 | -$14.8M | -33.3% |
| FY2016 | -$11.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice